10-Q: Quarterly report
Bellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder Meeting
As previously announced, on May 10, 2024, Bellevue Life Sciences Acquisitions Corp. (Nasdaq: BLAC) ("BLAC") convened a special meeting of...
OSR Holdings and SillaJen Have Entered Into a Memorandum of Understanding to Collaboratively Pursue the Development of Innovative Therapeutics and Enter the U.S. Market
SPAC Bellevue Life Sciences to Merge With South Korea's OSR
Bellevue Life Sciences Acquisition: Shares of Combined Co., OSR Biosciences, Inc., Expected to Trade on Nasdaq >BLACU
Bellevue Life Sciences Acquisition: Shares of Combined Co., OSR Biosciences, Inc., Expected to Trade on Nasdaq >BLACU
OSR Holdings Co., Ltd. Enters Into Business Combination Agreement With Bellevue Life Sciences Acquisition Corp.
Bellevue Life Sciences Acquisition Corp. (Nasdaq: BLAC), a publicly traded special purpose acquisition company ("BLAC"), and OSR Holdings Co., Ltd....
Bellevue Life Sciences Acquisition Plans to Take OSR Holdings Public in SPAC Merger Deal
Bellevue Life Sciences Acquisition (BLAC), a blank-check company, signed an exclusive nonbinding letter of intent to merge with OSR Holdings in a deal that would take the health-care company public. B
OSR Holdings Expected to Be Public in the 4Q >BLACU
OSR Holdings Expected to Be Public in the 4Q >BLACU
Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination
OSR Holdings expected to be public in the fourth quarter of 2023 BELLEVUE, Wash. and SEOUL, South Korea, July 11, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC), a publicly traded special
Bellevue Life Sciences Acquisition Corp. Announces Separate Trading of Its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023
BELLEVUE, Wash., March 14, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (the "Company") announced that holders of the 6,900,000 units sold in the Company's initial public offering, i
Bellevue Life Sciences Acquisition Corp. Announces Closing of $60 Million Initial Public Offering
BELLEVUE, Wash., Feb. 14, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLACU, the ", Company", )), a newly organized blank check company incorporated in Delaware, today announced that it
Bellevue Life Sciences Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
BELLEVUE, Wash., Feb. 10, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (the "Company") today announced the pricing of its initial public offering of 6,000,000 units at a price of $10.00 per unit.
Bellevue Life Sciences Acquisition Corp.: Each Unit Consists of One Share, One Redeemable Warrant and One Right
Bellevue Life Sciences Acquisition Corp.: Each Unit Consists of One Share, One Redeemable Warrant and One Right
BRIEF-Blank Check Co, Bellevue Life Sciences Acquisition Corp Files For IPO Of Up To $60 Million - SEC Filing
April 29 (Reuters) - Bellevue Life Sciences Acquisition Corp:* BLANK CHECK CO, BELLEVUE LIFE SCIENCES ACQUISITION CORP FILES FOR IPO OF UP TO $60 MILLION - SEC FILING* BELLEVUE LIFE SCIENCES ACQUISITI
No Data